As more researchers search for: there has also been a growing focus on: product quality supplier transparency batch testing contamination control research reliability At the same time, the rapid expansion of the market has led to a rise in low-transparency suppliers offering products with little documentation or quality assurance
Liver and kidney context matter for research compounds without mature human safety data
has acted as consultant, advisory board member and speaker for Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi, an advisory board member Lexicon, Pfizer, ShouTi Pharma Inc, AstraZeneca and Medtronic and as a speaker for AstraZeneca, Napp Pharmaceuticals, Novartis and Amgen
AI models integrating these variables could forecast expected weight loss and side effect risk, guiding treatment selection and dose titration